A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.
The innate immune system employs Toll-like receptors (TLRs) for the detection of invading microorganisms based on distinct molecular patterns. For example, TLR9 is activated by microbial DNA and also by short therapeutic CpG-containing oligonucleotides (CpG-ODN). TLR9 activation leads to the product...
Автори: | Kubarenko, A, Ranjan, S, Rautanen, A, Mills, T, Wong, S, Vannberg, F, Neumaier, M, Bekeredjian-Ding, I, Hill, A, Ahmad-Nejad, P, Weber, A |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2010
|
Схожі ресурси
Схожі ресурси
-
Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9
за авторством: Avalos, Ana M., та інші
Опубліковано: (2014) -
MyD88 adaptor-like D96N is a naturally occurring loss-of-function variant of TIRAP.
за авторством: George, J, та інші
Опубліковано: (2010) -
Immunotherapeutic Potential of CpG Oligonucleotides in Chickens
за авторством: Arshud Dar, та інші
Опубліковано: (2009-04-01) -
CpG Oligonucleotides as Cancer Vaccine Adjuvants
за авторством: Hidekazu Shirota, та інші
Опубліковано: (2015-05-01) -
Introduction of sugar-modified nucleotides into CpG-containing antisense oligonucleotides inhibits TLR9 activation
за авторством: Tokuyuki Yoshida, та інші
Опубліковано: (2024-05-01)